The WSX-1 pathway restrains intestinal T-cell immunity

International Immunology

Volumn 23, Issue 2, 2011, Pages 129-137

  McAleer, Jeremy P ^a,c   Saris, Christiaan J M ^b   Vella, Anthony T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b AMGEN INC   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; Lamina propria; LPS; Superantigen

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; PROTEIN WSX 1; STAPHYLOCOCCUS ENTEROTOXIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; IMMUNIZATION; LAMINA PROPRIA; LYMPHOCYTE DIFFERENTIATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TH17 CELL;

EID: 79551624297     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq464     Document Type: Article

References (68)

1. Magram, J., Connaughton, S. E., Warrier, R. R. et al. 1996. IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471.
2. Oppmann, B., Lesley, R., Blom, B. et al. 2000. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715.
3. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910.
4. Murphy, C. A., Langrish, C. L., Chen, Y. et al. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951.
5. Pflanz, S., Timans, J. C., Cheung, J. et al. 2002. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 16:779.
6. Pflanz, S., Hibbert, L., Mattson, J. et al. 2004. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 172:2225.
7. Batten, M., Li, J., Yi, S. et al. 2006. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7:929.
8. Stumhofer, J. S., Laurence, A., Wilson, E. H. et al. 2006. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 7:937.
9. Yoshimura, T., Takeda, A., Hamano, S. et al. 2006. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J. Immunol. 177:5377.
10. Villarino, A., Hibbert, L., Lieberman, L. et al. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19:645.
11. Holscher, C., Holscher, A., Ruckerl, D. et al. 2005. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis. J. Immunol. 174:3534.
12. Rosas, L. E., Satoskar, A. A., Roth, K. M. et al. 2006. Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to Leishmania donovani infection but develop severe liver immunopathology. Am. J. Pathol. 168:158.
13. Awasthi, A., Carrier, Y., Peron, J. P. et al. 2007. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8:1380.
14. Fitzgerald, D. C., Zhang, G. X., El-Behi, M. et al. 2007. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8:1372.
15. Stumhofer, J. S., Silver, J. S., Laurence, A. et al. 2007. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8:1363.
16. Collison, L. W., Workman, C. J., Kuo, T. T. et al. 2007. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 450:566.
17. Hashimoto, S. I., Suzuki, T., Nagai, S., Yamashita, T., Toyoda, N. and Matsushima, K. 2000. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 96:2206.
18. Schuetze, N., Schoeneberger, S., Mueller, U., Freudenberg, M. A., Alber, G. and Straubinger, R. K. 2005. IL-12 family members: differential kinetics of their TLR4-mediated induction by Salmonella enteritidis and the impact of IL-10 in bone marrow-derived macrophages. Int. Immunol. 17:649.
19. McAleer, J. P., Liu, B., Li, Z. et al. 2010. Potent intestinal Th17 priming through peripheral lipopolysaccharide-based immunization. J. Leukoc. Biol. 88:21.
20. Cucak, H., Yrlid, U., Reizis, B., Kalinke, U. and Johansson-Lindbom, B. 2009. Type I interferon signaling in dendritic cells stimulates the development of lymph-node-resident T follicular helper cells. Immunity 31:491.
21. Yoshida, H., Hamano, S., Senaldi, G. et al. 2001. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15:569.
22. Weigmann, B., Tubbe, I., Seidel, D., Nicolaev, A., Becker, C. and Neurath, M. F. 2007. Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue. Nat. Protoc. 2:2307.
23. McAleer, J. P., Zammit, D. J., Lefrancois, L., Rossi, R. J. and Vella, A. T. 2007. The lipopolysaccharide adjuvant effect on T cells relies on nonoverlapping contributions from the MyD88 pathway and CD11c+ cells. J. Immunol. 179:6524.
24. Unkeless, J. C. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J. Exp. Med. 150:580.
25. Marrack, P. and Kappler, J. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705.
26. Vella, A. T., McCormack, J. E., Linsley, P. S., Kappler, J. W. and Marrack, P. 1995. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 2:261.
27. Tokoyoda, K., Zehentmeier, S., Hegazy, A. N. et al. 2009. Professional memory CD4+ T lymphocytes preferentially reside and rest in the bone marrow. Immunity 30:721.
28. Lefrancois, L. and Masopust, D. 2002. T cell immunity in lymphoid and non-lymphoid tissues. Curr. Opin. Immunol. 14:503.
29. Iwakura, Y., Nakae, S., Saijo, S. and Ishigame, H. 2008. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol. Rev. 226:57.
30. Troy, A. E., Zaph, C., Du, Y. et al. 2009. IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis. J. Immunol. 183:2037.
31. Becker, C., Wirtz, S., Blessing, M. et al. 2003. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112:693.
32. Artis, D., Villarino, A., Silverman, M. et al. 2004. The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity. J. Immunol. 173:5626.
33. Bancroft, A. J., Humphreys, N. E., Worthington, J. J., Yoshida, H. and Grencis, R. K. 2004. WSX-1: a key role in induction of chronic intestinal nematode infection. J. Immunol. 172:7635.
34. Schmidt, C., Giese, T., Ludwig, B. et al. 2005. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm. Bowel Dis. 11:16.
35. Wang, S., Miyazaki, Y., Shinozaki, Y. and Yoshida, H. 2007. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J. Immunol. 179:6421.
36. Chen, Q., Ghilardi, N., Wang, H. et al. 2000. Development of Th1-type immune responses requires the type I cytokine receptor TCCR. Nature 407:916.
37. Lucas, S., Ghilardi, N., Li, J. and de Sauvage, F. J. 2003. IL-27 regulates IL-12 responsiveness of naive CD4+ T cells through Stat1-dependent and -independent mechanisms. Proc. Natl Acad. Sci. USA. 100:15047.
38. Takeda, A., Hamano, S., Yamanaka, A. et al. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170:4886.
39. Maxwell, J. R., Yadav, R., Rossi, R. J. et al. 2006. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J. Immunol. 177:234.
40. McAleer, J. P., Rossi, R. J. and Vella, A. T. 2009. Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF. J. Immunol. 182:5322.
41. Shin, H. C., Benbernou, N., Fekkar, H., Esnault, S. and Guenounou, M. 1998. Regulation of IL-17, IFN-gamma and IL-10 in human CD8(+) T cells by cyclic AMP-dependent signal transduction pathway. Cytokine 10:841.
42. Happel, K. I., Zheng, M., Young, E. et al. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170:4432.
43. Vanden Eijnden, S., Goriely, S., De Wit, D., Willems, F. and Goldman, M. 2005. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naive T cells in human. Eur. J. Immunol. 35:469.
44. He, D., Wu, L., Kim, H. K., Li, H., Elmets, C. A. and Xu, H. 2006. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J. Immunol. 177:6852.
45. Kryczek, I., Wei, S., Vatan, L. et al. 2007. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J. Immunol. 179:1423.
46. Hamada, H., Garcia-Hernandez Mde, L., Reome, J. B. et al. 2009. Tc17, a unique subset of CD8 Tcells that can protect against lethal influenza challenge. J. Immunol. 182:3469.
47. Intlekofer, A. M., Banerjee, A., Takemoto, N. et al. 2008. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321:408.
48. Hisada, M., Kamiya, S., Fujita, K. et al. 2004. Potent antitumor activity of interleukin-27. Cancer Res 64:1152.
49. Matsui, M., Moriya, O., Belladonna, M. L. et al. 2004. Adjuvant activities of novel cytokines, interleukin-23 (IL-23) and IL-27, for induction of hepatitis C virus-specific cytotoxic T lymphocytes in HLA-A*0201 transgenic mice. J. Virol. 78:9093.
50. Salcedo, R., Stauffer, J. K., Lincoln, E. et al. 2004. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: role for CD8+ T cells. J. Immunol. 173:7170.
51. Mayer, K. D., Mohrs, K., Reiley, W. et al. 2008. Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infection. J. Immunol. 180:693.
52. Muralimohan, G., Rossi, R. J., Guernsey, L. A., Thrall, R. S. and Vella, A. T. 2008. Inhalation of Staphylococcus aureus enterotoxin A induces IFN-gamma and CD8 T cell-dependent airway and interstitial lung pathology in mice. J. Immunol. 181:3698.
53. Cooper, A. M. and Khader, S. A. 2008. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol. Rev. 226:191.
54. Lefrancois, L., Parker, C. M., Olson, S. et al. 1999. The role of beta7 integrins in CD8 T cell trafficking during an antiviral immune response. J. Exp. Med. 189:1631.
55. Ouaked, N., Mantel, P. Y., Bassin, C. et al. 2009. Regulation of the foxp3 gene by the Th1 cytokines: the role of IL-27-induced STAT1. J. Immunol. 182:1041.
56. Neufert, C., Becker, C., Wirtz, S. et al. 2007. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1. Eur. J. Immunol. 37:1809.
57. Batten, M., Kljavin, N. M., Li, J., Walter, M. J., de Sauvage, F. J. and Ghilardi, N. 2008. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J. Immunol. 180:2752.
58. Huber, M., Steinwald, V., Guralnik, A. et al. 2008. IL-27 inhibits the development of regulatory T cells via STAT3. Int. Immunol. 20:223.
59. Lochner, M., Peduto, L., Cherrier, M. et al. 2008. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J. Exp. Med. 205:1381.
60. Zhou, L., Lopes, J. E., Chong, M. M. et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453:236.
61. Voo, K. S., Wang, Y. H., Santori, F. R. et al. 2009. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl Acad. Sci. USA. 106:4793.
62. Diveu, C., McGeachy, M. J., Boniface, K. et al. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182:5748.
63. Ivanov, I. I., Frutos Rde, L., Manel, N. et al. 2008. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4: 337.
64. Ivanov, I. I., Atarashi, K., Manel, N. et al. 2009. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485.
65. Honda, K., Nakamura, K., Matsui, N. et al. 2005. T helper 1-inducing property of IL-27/WSX-1 signaling is required for the induction of experimental colitis. Inflamm. Bowel Dis. 11: 1044.
66. Villarino, A. V., Artis, D., Bezbradica, J. S. et al. 2008. IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD. Int. Immunol. 20:739.
67. Nieuwenhuis, E. E., Neurath, M. F., Corazza, N. et al. 2002. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice. Proc. Natl Acad. Sci. USA. 99:16951.
68. Li, C. S., Zhang, Q., Lee, K. J. et al. 2009. Interleukin-27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J. Gastroenterol. Hepatol. 24: 1692.